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Cell migration during wound healing requires adhe-
sion receptor turnover to enable the formation and
disassembly of cell-extracellular matrix contacts.
Although recent advances have improved our under-
standing of integrin trafficking pathways, it is not
known how extracellular ligand engagement controls
receptor dynamics. Using atomic force microscopy,
we have measured cell avidity for fibronectin and
defined a mechanism for the outside-in regulation
of a5b1-integrin. Surprisingly, adhesive strength
was attenuated by the syndecan-4-binding domain
of fibronectin due to a rapid triggering of a5b1-integ-
rin endocytosis. Association of syndecan-4 with
PKCa was found to trigger RhoG activation and
subsequent dynamin- and caveolin-dependent in-
tegrin uptake. Like disruption of syndecan-4 or cave-
olin, gene disruption of RhoG in mice was found to
retard closure of dermal wounds due to a migration
defect of the fibroblasts and keratinocytes of RhoG
null mice. Thus, this syndecan-4-regulated integrin
endocytic pathway appears to play a key role in
tissue repair.
INTRODUCTION
The uninjured dermis of adult mammals comprises predomi-
nantly collagen and nonmigratory fibroblasts, and contains
only very low levels of fibronectin. Uponwounding, blood plasma
floods from ruptured vessels into the damaged tissue, triggering
recruitment of fibroblasts into the wound bed and leading to
wound contraction (Shaw and Martin, 2009). The development
of strategies to accelerate or control repair processes requires
an understanding of how changes in the extracellular matrix
(ECM) are communicated across the plasmamembrane to direct
cell behavior. a5b1-integrin is the prototypic fibronectin receptor,
but fibronectin-dependent signaling depends upon simulta-
neous engagement of the transmembrane proteoglycan, synde-
can-4, which acts as a fibronectin coreceptor (Morgan et al.,Developm2007). Disruption of the Sdc4 gene in mice results in delayed
wound healing due to compromised motility of fibroblasts,
demonstrating a clear role for syndecan-4 in the healing process
(Echtermeyer et al., 2001). In vitro, cooperative engagement of
syndecan-4 and a5b1-integrin by fibronectin causes transient
activation of Rac1 (Bass et al., 2007), rapid inhibition of RhoA
(Bass et al., 2008), and subsequent reactivation of RhoA (Dovas
et al., 2006), thus promoting cycles of membrane protrusion fol-
lowed by cytoskeletal contraction that are necessary for cell
migration.
The direct relationship between syndecan-4 and a5b1-integrin
has not been explored. Syndecan-4 activates PKCa by direct
association (Koo et al., 2006), and there is evidence that PKCa
can cause the activation (Han et al., 2006) or endocytosis of
integrin (Ng et al., 1999). Such reports raise the possibility that
syndecan-4-dependent PKCa regulation might influence the
activity or surface availability of integrins in fibronectin-stimu-
lated fibroblasts. In this study, we use atomic force microscopy
(AFM) to measure directly the effect of syndecan-4 engagement
on cell avidity for the integrin-binding domain of fibronectin. We
find that, contrary to expectation, engagement of syndecan-4
reduces cell avidity for fibronectin by inducing integrin endocy-
tosis. We delineate the signaling pathway by which syndecan-
4 induces integrin redeployment, and finally demonstrate that
genetic disruption of the key signaling intermediary results in
a fibroblast-mediated healing defect. Based on these observa-
tions, we redefine the function of syndecan-4 as follows: first,
syndecan-4 acts as an integrin regulator, rather than a corecep-
tor; second, syndecan-4 induces integrin trafficking rather than
stabilization; and third, each of these syndecan-4-regulated
steps is necessary for efficient wound repair. These advances
provide an explanation for how fibroblasts recognize the change
in ECM composition following injury and why they become more
motile in a fibronectin-rich environment.
RESULTS
Engagement of Syndecan-4 Reduces Cell Avidity
for Integrin Ligands
Cell migration requires modulation of the adhesive strength
by formation and disassembly of integrin-mediated adhesive
contacts. To probe the contributions of integrins and syndecans
to the generation of adhesion strength, we used AFM tomeasureental Cell 21, 681–693, October 18, 2011 ª2011 Elsevier Inc. 681
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Figure 1. Engagement of Syndecan-4 Reduces Cell Avidity for Fibronectin
(A) Individual, cantilever-mounted fibroblasts were contacted with fibronectin fragment-coated surfaces and then retracted.
(B) During retraction, deflection of the calibrated cantilever was recorded to obtain measurements of the maximum applicable force, number of individual tethers,
and the total work required to detach the cell from the substrate.
(C) ELISA analysis of coated ligands to ensure equivalent density of integrin-bindingmotifs between the integrin-binding fragment of fibronectin (50K, closed bars)
and fibronectin (open bars).
(D) Unbinding force curves as a fibroblast was withdrawn from 50K or fibronectin in the absence or presence of a soluble syndecan-4-binding fragment of
fibronectin (H/0).
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series of 5 s contacts were made between single fibroblasts,
captured on a cantilever, and matrix protein-coated glass (Fig-
ure 1A), and the deflection of the cantilever was recorded as
the cells were withdrawn from the glass surface (Figure 1B).
This arrangement allowed us to record the unbinding energy
for the same cell after contact with different surfaces, and
thereby enabled avidity changes to be tracked in single cells
rather than being averaged across populations. Analysis of indi-
vidual cells also ensured that all data were obtained from live
cells because cell death caused immediate loss of unbinding
‘‘steps’’ and a fall in maximum force. The 5 s contact times
were sufficient for integrin binding, but not cytoskeletal reorgani-
zation (Taubenberger et al., 2007), allowing specific interrogation
of integrin regulation.
To test the effect of syndecan-4 engagement on cell avidity
for a5b1-integrin ligand, cells were contacted with patches of
plasma fibronectin, which contains a5b1-integrin- and syndecan-
4-binding motifs, or patches of a recombinant 50 kDa
fragment of fibronectin (50K) encompassing the binding site for
a5b1-integrin alone. Equivalent density of integrin ligand on the
fibronectin and 50K surfaces was tested and confirmed by
ELISA using a monoclonal antibody directed against the integrin-
binding domain of fibronectin (Figure 1C).
Withdrawal of a fibroblast from either 50K or fibronectin re-
sulted in an unbinding curve with several features: (1) maximum
deflection represented the maximum force that could be applied
before integrin tethers were broken; (2) area under the curve rep-
resented total energy required to detach a cell from the ECM;
and (3) breakage of individual tetherswas represented by a series
of steps on the curve (Figures 1B and 1D). Because syndecan-4
engagement is known to activate adhesive signals and drive
focal adhesion formation (Bass et al., 2007), we had predicted
that more energy would be required to detach a cell from fibro-
nectin than 50K. In fact the opposite effect was observed (Fig-
ures 1D and 1E). Stimulation of cells with a soluble syndecan-
binding fragment of fibronectin, comprising type III repeats
12–15 (H/0), also resulted in low unbinding energy that no longer
varied between 50K and fibronectin surfaces, suggesting that
the different binding to fibronectin and 50Kwas due to syndecan
engagement (Figures 1D and 1E). A striking feature was the
highly reproducible nature of the experiment. Although the abso-
lute values obtained from different cells varied, the same
response was observed with every cell tested (see Figure S1A
available online). Like unbinding energy, the maximum appli-
cable force also decreased upon syndecan-4 engagement
(Figures 1D and 1F).
To establish specific involvement of syndecan-4, we indepen-
dently blocked either the receptor or ligand. H/0 that had been(E and F) Quantification of the energy (E) or maximum force (F) required to detac
(G) H/0, preincubated with 10 mg/ml heparin, was used as an inactivated syndec
(H–J) The specific role of syndecan-4 was tested by comparing responses of s
syndecan-4 cDNA (J).
(K) Individual unbinding energy measurements as fibroblasts were contacted se
depicts pooled data from three separate cells.
(L) Time course of unbinding energy from 50K upon addition of soluble H/0.
All values represent at least 80 measurements per condition from five to nine ex
tested by ANOVA. See also Figure S1.
Developmpreincubated with heparin, thus blocking interaction with the
syndecan-4 polysaccharide chains, had no effect on unbinding
energy (Figure 1G). Sdc4/ MEFs failed to respond to fibro-
nectin or soluble H/0 (Figure 1H), unlike wild-type MEFs or those
rescued by re-expression of the full-length syndecan-4 cDNA
(Figures 1I and 1J). To identify the integrin regulated by synde-
can-4, human fibroblasts were treated with inhibitory mono-
clonal antibodies. An activity-neutral antibody (K20) had only a
very minor effect on unbinding energy, possibly due to steric
obstruction, and did not block the response to syndecan-4
engagement by either fibronectin or H/0 (Figure S1B). By con-
trast, inhibitors of b1-integrin (mAb13, Figure S1C) or a5-integrin
(mAb16, Figure S1D) almost completely blocked binding to
50K or fibronectin. The residual interaction was weaker than
that seen after engagement of syndecan-4 and probably due
to weak electrostatic interactions of the cell membrane. An
inhibitor of avb3-integrin (17E6, Figure S1E) had no effect on
unbinding energy. These experiments confirm a role for
syndecan-4 and demonstrate that the rapid interaction between
fibroblasts and fibronectin is mediated by a5b1-integrin exclu-
sively, rather than avb3-integrin, which is noteworthy in itself.
We next used sequential time course analyses to gain further
information about the nature of the syndecan-4-integrin relation-
ship. We recorded a series of contacts with 50K, followed by
a series of contacts with fibronectin, before making more con-
tacts with 50K. Contact with fibronectin immediately reduced
unbinding energy compared to 50K. This very rapid response
identifies syndecan-4 as a hair trigger integrin regulator and indi-
cates that receptors and signaling intermediaries are in close
proximity even before fibronectin binding (Figures 1K and S1F).
Upon returning to 50K, the cell recovered, demonstrating that
avidity suppression is a reversible signaling event, and not due
to cell damage. Plotting the time course of H/0 action (Figure 1L)
confirmed that the reduction in avidity was very fast (t½ =
2.6 min), even though the soluble H/0 was not applied directly
to the surface of the cell. The rapid response to diffuse ligand
was consistent with the 5 s response when syndecan-4 and
integrin were engaged in close proximity by contact with fibro-
nectin. Taken together, these experiments reveal negative regu-
lation of integrin by a molecule previously considered to be
a coreceptor.
Integrin Regulation: Inactivation versus Surface
Availability
Initial experiments identified reduction in the avidity of cells for
fibronectin upon syndecan-4 engagement. The first step in
resolving the mechanism was to distinguish whether change in
avidity was a consequence of individual bond weakening or
a reduction in the number of bondsmade. Inspection of the forceh a fibroblast.
an-4 ligand.
yndecan-4 null MEFs (H), wild-type MEFs (I), and null MEFs reexpressing the
quentially with 50K (circles), fibronectin (crosses), and then 50K again. Graph
periments. Error bars represent standard error of the mean; significance was
ental Cell 21, 681–693, October 18, 2011 ª2011 Elsevier Inc. 683
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similar distribution of step size and similar average step size
when cells were detached from 50K, fibronectin, or 50K in the
presence of H/0 (Figures 2A and 2B). The consistency in step
size indicated that bond strength must be similar under all condi-
tions. Instead, the difference in total force or energy required for
detachment was due to a reduction in the number of unbinding
steps (Figure 2C). Integrins can be found on the cell surface in
active and inactive conformations (Byron et al., 2009), and so
the negative effect of syndecan-4 on a5b1-integrin could be
achieved in two ways: reduction in either the activity of integrin
or the abundance of integrin on the cell surface. These possibil-
ities were distinguished by forcing a5b1-integrin into the active
conformation using two different monoclonal antibodies (9EG7
and TS2/16; Byron et al., 2009). Application of either antibody
increased the energy required to detach cells from 50K (Figures
2D and 2E; p = 0.017) as expected. Despite the enforced activa-
tion of surface integrin, engagement of syndecan-4 still caused
a reduction in unbinding energy, demonstrating that syndecan-4
engagement lowers avidity by reducing the total number of
a5b1-integrins on the cell surface, rather than by modulating
the activation state of individual receptors.
Internalization of b1-integrin could be visualized by using total
internal reflection fluorescence (TIRF) microscopy to follow
disappearance of GFP-b1-integrin from the focal plane. Cells
spread on 50K adhere using small integrin clusters around the
cell periphery. The integrin clusters were stable on 50K, but
upon application of H/0 there was a reduction in cluster intensity
within 1 min (Figures 2F and 2H and Movie S1A) that did not
occur when H/0 was precomplexed with heparin (Figures 2G
and 2H and Movie S1B). Thus, both atomic force and time-lapse
experiments are supportive of a mechanism involving internali-
zation of b1-integrin upon engagement of syndecan-4. In turn,
this led us to look for a syndecan-4-dependent mechanism of in-
tegrin endocytosis.
Syndecan-4-Dependent Endocytosis of a5b1-Integrin
Dynamin is responsible for scission of endocytic vesicles from
the plasma membrane and integrin internalization (Ng et al.,
1999). We used siRNA targeted against the nonneuronal dyna-
min isoform, dynamin-2, to test the necessity of endocytosis
for reduction of unbinding energy. The response of fibroblasts
to syndecan-4 engagement was unaffected by transfection
with nontargeted siRNA (Figure 3A). However, reduction of dyna-
min-2 expression to less than 10% of control blocked the reduc-
tion in unbinding energy, indicating that syndecan-4 does indeed
reduce cell avidity for fibronectin by triggering endocytosis of
a5b1-integrin (Figures 3B and S2A). Furthermore, addition of
a pharmacological dynamin inhibitor, MiTMAB, blocked the sus-
tained syndecan-4-induced endocytosis of cells already treated
with H/0 and restored unbinding energy to the level observed
with 50K alone (Figure 3C). The recovery of unbinding energy
indicates that the integrins are in dynamic equilibrium between
vesicles and the plasma membrane, and that syndecan-4
engagement simply shifts the equilibrium away from the
membrane by increasing endocytosis. a5b1-integrin is recycled
through an Arf6-dependent pathway (Caswell and Norman,
2006). When Arf6 expression was reduced by RNAi, unbinding
energy still decreased when a cell was moved from 50K to fibro-684 Developmental Cell 21, 681–693, October 18, 2011 ª2011 Elsevnectin but did not recover upon return to 50K (Figures S2C–S2E).
Thus, it appears that active recycling plays a role in integrin rede-
ployment, but the immediate reduction in cell avidity is entirely an
endocytic event.
Endocytic pathways can be divided into clathrin-dependent or
caveolin-dependent mechanisms (Caswell and Norman, 2006).
RNAi-mediated reduction of clathrin heavy-chain expression, to
less than 10%, had no effect on the cell response to syndecan-4
ligand (Figure 3D). By contrast, reduction in caveolin ex-
pression to less than 20% blocked the reduction in unbinding
energy upon syndecan-4 engagement (Figures 3E and S2B).
Likewise, reduction of caveolin expression in MEFs blocked H/
0-triggered disappearance of GFP-b1-integrin from the TIRF
plane (Figure 3F). Through these experiments, we identify dyna-
min- and caveolin-dependent endocytosis of a5b1-integrin as
a consequence of syndecan-4 engagement.
To complement AFM studies, trafficking of integrin and cave-
olin was investigated further by biochemical fractionation of cells
into plasmamembrane and vesicle compartments. The segrega-
tion of membrane fractions was validated by blotting for marker
molecules (Figure 4A). Vesicle markers, early endosome-associ-
ated molecule 1 (EEA1) and Rab4, were found exclusively in the
small vesicle/soluble fraction, as was tubulin. By contrast, the
sodium-potassium ATPase transporter, which is constitutively
localized to the cell surface, was restricted to the plasma
membrane fraction. As expected, b1-integrin was found in both
plasma membrane and vesicle fractions (Figure 4A). To test
redistribution, fibroblasts were spread onto 50K for 2 hr and
then stimulated with H/0 for 0–90 min before fractionating and
blotting the plasma membrane fraction. As predicted from
AFM, a5b1-integrin was internalized in response to syndecan-4
engagement, but over a longer time period (90 min) was found
to return to the membrane (Figures 4B and 4C). This second
phase of redistribution is important because unidirectional integ-
rin internalization would result in cell detachment, whereas
a biphasic response would cause integrin redeployment and
formation of new adhesion complexes and thereby enable cell
migration. The endocytic phase was slower (t½ = 6.0 min) than
that detected by atomic force (t½ = 2.6 min) because, in fraction-
ation experiments, integrin is engaged by immobilized 50K that
would oppose internalization. Caveolin also redistributed over
a similar time period, confirming that syndecan-4 triggers caveo-
lar endocytosis (Figure 4D). Unlike the integrin redistribution, the
decrease in membrane-associated caveolin was preceded by
a slight increase (Figures 4B and 4D). The same trend was
observed for pY14-caveolin (Figure 4B), which is necessary for
caveolin uptake (del Pozo et al., 2005). We propose that H/0 trig-
gers immediate internalization of caveolin-coatedmembrane but
that there is also recruitment of membrane-proximal caveolin
that enables a large-scale endocytic response.
Each of the experiments thus far has examined the influence of
syndecan-4 in the context of simultaneous integrin engagement.
If syndecan-4 is to be considered an independent regulator of in-
tegrin trafficking in response to fibronectin, one would expect
syndecan-4-dependent trafficking of both ligated and ligand-
free integrin. H/0 stimulation of fibroblasts in suspension still
caused integrin redistribution between plasma membrane and
vesicle fractions (t½ = 3.7 min, Figure 4E), demonstrating that
syndecan-4 regulates integrin endocytosis, independently ofier Inc.
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Figure 2. Syndecan-4 Causes Endocytosis Rather than Inactivation of Integrin
(A) Frequency distribution of the force required to unbind individual tethers as a cell is retracted from 50K (black), fibronectin (gray), or 50K in the presence of
H/0 (white). The graph represents 337 unbinding steps from a single cell. The experiment was repeated on four separate occasions.
(B) Average force required during individual unbinding steps. Values represent 1069 unbinding events from four separate experiments.
(C) Number of unbinding steps per retraction curve. Values represent the average of 40 curves per condition from 4 separate experiments.
(D and E) Response of cells to syndecan-4 engagement after surface integrin is forced into the active conformation using integrin-activating antibodies: 9EG7 (D)
or TS2/16 Fab fragment (E).
(F–H) Time-lapse TIRF imaging of b1-integrin-GFP in the adhesion plane, comparing 5 min prestimulation with 5 min poststimulation when cells were treated with
H/0 (F) or H/0 complexed with heparin (G). Scale bars represent 5 mm. (H) Intensity change of 20 adhesions per cell, 9 cells per condition.
Error bars represent standard error of the mean; significance was tested by ANOVA. See also Movie S1.
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Figure 3. Syndecan-4 Engagement Drives Reduction of Cell Avidity
through Dynamin-Dependent, Caveolin-Dependent Endocytosis of
a5b1-Integrin
(A, B, D, and E) The effect of syndecan-4 engagement on unbinding energy
using fibroblasts transfectedwith control (Ctrl) (A), dynamin-2-targeted (Dnm2)
(B), clathrin heavy-chain-targeted (D), or caveolin-1-targeted (E) siRNA.
Western blots compare expression of appropriate molecules between control
and siRNA-transfected populations. Knockdown of caveolin-1 caused
concomitant loss of caveolin-2, as previously reported (Razani et al., 2001).
(C) Unbinding energy of fibroblasts treated with soluble H/0, and subsequently
treated with the dynamin inhibitor MiTMAB to block the endocytic signal.
(F) Time-lapse TIRF imaging of b1-integrin-GFP in the adhesion plane,
comparing MEFs transfected with control or caveolin-targeted RNAi oligos.
Images represent 5 min pre- or post-H/0 stimulation. Scale bars represent
5 mm. Values represent at least 25 measurements per condition from 4
separate experiments. TIRF analysis summarizes intensity changes of 20
adhesions per cell, 9 cells per condition.
Error bars represent standard error of the mean; significance was tested by
ANOVA. See also Figure S2 and Movie S2.
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that syndecan-4 is a trigger of caveolar endocytosis that rede-
ploys integrins upon appearance of fibronectin. This model
contrasts with the canonical role of syndecan-4 in stabilizing
focal adhesions and provides a more logical explanation of
how syndecan-4 promotes cell migration during tissue repair.
Syndecan-4 Drives Endocytosis through the Activation
of PKCa and RhoG
The redistribution of caveolin, in response to H/0, positions cave-
olin-dependent endocytosis downstream of syndecan-4, but
upstream of a5b1-integrin, in a signaling cascade. Our next aim
was to elucidate the link between syndecan-4 and caveolar
trafficking. The cells used in this study express syndecan-1, -2,
and -4 (Bass et al., 2007), yet disruption of syndecan-4 expres-
sion was sufficient to block fibronectin-dependent endocytosis
(Figure 1H). Syndecan-4 is unique among syndecan family
members in binding and activating PKCa (Koo et al., 2006),
making PKCa a prime candidate to connect syndecan and cav-
eolin. Reduction of PKCa expression to less than 10% by RNAi
blocked the reduction of unbinding energy upon syndecan-4
engagement (Figure 5A). Similarly, expression of a PKCa-binding
mutant of syndecan-4 (Y188L) failed to rescue the endocytic
response in Sdc4/ MEFs (Figure 5B), whereas re-expression
of wild-type syndecan-4 restored modulation of unbinding
energy (Figure 1J). The effect of H/0 could be mimicked by acti-
vating PKCdirectly with 100 nMphorbol 12-myristate 13-acetate
(PMA) (Figure 5C). Treatment of cells with vehicle DMSO had no
effect on unbinding energy or the response to fibronectin (Fig-
ure 5D). Curiously, the response to PMA was slower than the
response to H/0 (H/0, t½ = 2.6 min; PMA, t½ = 7.7 min). We
suggest two equally plausible explanations because, first,
syndecan-4 is a better activator of PKCa than are lipid activators
as suggested previously (Oh et al., 1998), and second, proximity
of syndecan-4 to a5b1-integrin means that syndecan-4 activates
PKCa in the correct location, rather than holistically throughout
the cell. Cells transfected with the siRNA targeted against cave-
olin failed to respond to PMA (Figure 5E), placing PKCa between
syndecan-4 and caveolin on the signaling cascade. Collectively,
these experiments show that the interaction between syndecan-
4 and PKCa is necessary for caveolin-dependent endocytosisier Inc.
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of a5b1-Integrin between the Plasma Membrane and Vesicles
(A) Fibroblast membranes were separated by centrifugation into a plasma
membrane fraction (Mem) and a small vesicle/soluble (Sol) fraction. Segre-
gation was verified by blotting for vesicle markers (EEA1 and Rab4), soluble
marker (tubulin), and plasma membrane marker (Na+ K+ ATPase transporter).
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(B) Western blot analysis of the redistribution of molecules when fibroblasts
prespread on 50K were stimulated with H/0 over a time course.
(C and D) Quantification of plasma membrane-associated b1-integrin (C) and
caveolin-1 (Cav-1) (D).
(E) Redistribution of plasma membrane-associated b1-integrin when fibro-
blasts in suspension were stimulated with H/0.
Error bars represent standard error of the mean of experiments repeated on
four to eight separate occasions; significance was tested by ANOVA.
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syndecan-4-PKCa-caveolin-endocytosis.
Our next aim was to identify the pathway activated by PKCa
upon syndecan-4 engagement. Although tyrosine phosphoryla-
tion of caveolin is necessary for endocytosis (Cao et al., 2002),
there are no reports that serine/threonine phosphorylation of
caveolin by PKCa is important. One possible endocytic mecha-
nism stems from the recent identification of a complex
comprising syndecan-4, RhoGDI, and RhoG (Elfenbein et al.,
2009). Elfenbein et al. (2009) reported a syndecan-4-dependent
phosphorylation of RhoGDI in response to growth factor stimula-
tion, which led to release and activation of RhoG. RhoG has
been linked to two processes: activation of Rac1 through theDevelopmELMO/Dock180 complex (Katoh et al., 2006) and caveolar
endocytosis of growth factor receptors (Samson et al., 2010).
Wild-type RhoG traffics from the plasma membrane to caveolar
vesicles, whereas constitutively active RhoG accumulates
preferentially in vesicles and accelerates internalization of
membrane cargoes (Prieto-Sa´nchez et al., 2006). We hypothe-
sized that RhoG might also trigger integrin endocytosis upon
engagement of syndecan-4 by fibronectin. We tested fibro-
nectin-dependent activation of RhoG by effector pull-down
using the N terminus of ELMO2 as bait. H/0 stimulation of fibro-
blasts spread on 50K caused a rapid increase in RhoG activity
within 10 min (Figure 5F), correlating with internalization of b1-
integrin (Figure 4C). Reduction of RhoG expression to less than
10% of control by RNAi blocked the syndecan-4-dependent
reduction in unbinding energy (Figures 5G and S3), disappear-
ance of GFP-b1-integrin from the TIRF plane (Figure 5H and
Movie S2), and loss of b1-integrin from the plasma membrane
fraction (Figure 5I), demonstrating that syndecan-4-dependent
activation of RhoG is indeed the trigger for integrin endocytosis.
We have already conjectured that the 5 s response to fibro-
nectin (Figure 1K) necessitates the existence of a preformed en-
docytic complex, and so we immunoprecipitated b1-integrin
from cells expressing GFP-RhoG. Not only did RhoG precipitate
with b1-integrin, but it was enriched in the complex associated
with inactive integrin (mAb13, Figure 5J). Caveolin was also en-
riched in the inactive integrin complex, indicating that ligand-
free integrin is primed for redeployment through an endocytic
pathway. As expected, talin was recruited preferentially to active
integrin (12G10). Neither RhoG nor caveolin was recruited to the
control transferrin receptor complex (OKT9). Preferential rede-
ployment of inactive b1-integrin, rather than ligated integrin,
refines the model of fibronectin-induced integrin mobilization
and explains why syndecan-4 induces integrin redeployment,
rather than cell detachment. The second necessary feature of
the integrin-RhoG complex is that RhoGDI should be present
in a preformed complex and be released upon syndecan-4
engagement. RhoGDI was indeed detected in the complex
when total GFP-b1-integrin, but not GFP alone, was immunopre-
cipitated from MEFs spread on 50K, using a GFP-Trap (Fig-
ure 5K). Ten minute stimulation with H/0, which coincided with
the peak in RhoG activity, caused a 46% reduction in bound
RhoGDI. Together, these experiments demonstrate that engage-
ment of syndecan-4 by fibronectin causes release of RhoGDI
from a b1-integrin complex and triggers a wave of RhoG activity
that preferentially redeploys inactive a5b1-integrin through an
endocytic mechanism. Combined with the existing knowledge
of the links from syndecan-4 to RhoG through PKCa and
RhoGDI, we have delineated the molecular pathway responsible
for integrin internalization upon exposure to fibronectin.
The Syndecan-4-RhoG-Caveolin Endocytic Cascade
Is Necessary for Wound Closure
Having identified RhoG as a key molecular link between
syndecan-4 and caveolin-dependent endocytosis in vitro, we
investigated the role of this pathway in vivo. Both Sdc4/ and
Cav1/ mice have similar and surprisingly mild phenotypes.
Both are viable and fertile, and suffer a delay in wound closure
that has been attributed to a defect in fibroblast migration
(Echtermeyer et al., 2001; Grande-Garcı´a et al., 2007; Razaniental Cell 21, 681–693, October 18, 2011 ª2011 Elsevier Inc. 687
030
20
10
U
nb
in
di
ng
 E
ne
rg
y 
/ x
10
-1
5  
J
PKCα KD
50K Fn 50K Fn
H/0Stimulus:
Tub
PKCα
C
trl
P
K
C
α
 K
DA
C
0
30
20
10
U
nb
in
di
ng
 E
ne
rg
y 
/ x
10
-1
5  
J Cav KD
50K Fn 50K Fn
PMAStimulus:
E
0
25
20
15
10
U
nb
in
di
ng
 E
ne
rg
y 
/ x
10
-1
5  
J
5
Y188L
50K Fn 50K Fn
H/0Stimulus:
B
F
0 5 10 20
H/0 stimulation (min)
Tubulin
RhoG-GTP
0 5 10 20
H/0 stimulation (min)
0
0.5
1.0
1.5
2.0
R
ho
G
 A
ct
iv
ity
2.5 p=0.0096
Caveolin
β1-Integrin
0
35
20
10
U
nb
in
di
ng
 E
ne
rg
y 
/ x
10
-1
5  
J
50K Fn 50K Fn
PMAStimulus:
30
p=7.7e-11 D
0
35
20
10
U
nb
in
di
ng
 E
ne
rg
y 
/ x
10
-1
5  
J
50K Fn 50K Fn
DMSOStimulus:
30 p=3.6e-7
p=0.48
p=1.2e-5
GFP-RhoG
12
G
10
m
A
b1
3
O
K
T9
0
1
2
3
RhoG Caveolin
E
nr
ic
hm
en
t t
o 
in
te
gr
in p=0.047 p=0.035
Talin
TfR
G
Tub
RhoG
C
trl
R
ho
G
 K
D
0
30
20
10
U
nb
in
di
ng
 E
ne
rg
y 
/ x
10
-1
5  
J RhoG KD
50K Fn 50K Fn
H/0Stimulus:
J
H T = 0 min T = 5 min
50
K
+H
/0
0.5
5
10
15
P
ix
el
 In
te
ns
ity
:
Tub
RhoG
C
trl
R
ho
G
 K
D - +
H/0
0
-30
-24
-18
-12
-6
%
 In
te
ns
ity
 c
ha
ng
e 
(m
in
-1
)
p=0.65
0
0.5
1.0
1.5
B
ou
nd
 R
ho
G
D
I /
 In
te
gr
in
+-
H/0
β1-GFP
RhoGDI
H/0:
K
p=0.009
0
1
2
0 10 30 60 90
H/0 stimulation (min)
M
em
br
an
e 
β 1
p=0.81 RhoG KDI
0 90603010
Mem β1-Int 
H/0 stimulation (min)
Sol Tubulin 
- +-
β1-GFPGFP
GFP
Tubulin
P
ul
l d
ow
n
Ly
sa
te
Figure 5. Regulation of PKCa and RhoG Is Responsible for Caveolin-Dependent Endocytosis in Response to Syndecan-4 Engagement
(A and B) The effect of syndecan-4 engagement on unbinding energy using MEFs transfected with PKCa-targeted siRNA (A) or expressing a PKCa-binding
mutant of syndecan-4 (B). The sequence of signals was resolved by direct activation of PKCa with 100 nM PMA.
(C–E) PMA treatment (C), control vehicle solvent (D), and PMA treatment (E) of fibroblasts transfected with caveolin (Cav)-targeted siRNA.
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Syndecan-4/RhoG/Caveolin Trigger Initiates Healinget al., 2001). Cav1/mice also suffer nondetrimental hyperpro-
liferation of some cell types. We hypothesized that if the healing
defects of the two mice are a consequence of a disruption in the
syndecan-4-RhoG-caveolin signaling cascade, then Rhog/
mice would suffer a similar defect. The Rhog/ mouse is also
viable and fertile, and the only documented phenotype is
a slightly enhanced immune response (Vigorito et al., 2004).
We investigated the closure of 4 mm punch wounds in
7-week-old Rhog/ mice by imaging the live mice for 6 days
postwounding, and measuring the wound area digitally.
Compared to wild-type or heterozygous littermates, Rhog/
mice exhibited a striking delay in wound closure, with a signifi-
cantly larger wound area at 1–3 days (Figure 6A). By day 5, the
wound areas of wild-type, heterozygous, and knockout mice
were comparable. Defects in wound contraction are generally
a consequence of impaired fibroblast migration into the defect,
where some subsequently differentiate into contractile myofibro-
blasts (Shaw and Martin, 2009). Macroscopic or histological
inspection of theRhog/mice suggested such a defect (Figures
6A and 6B). Thus, histology of 3 day skin sections revealed the
appearance of a-smooth muscle actin-positive myofibroblasts
around the wound sites of wild-type and heterozygous mice. In
Rhog/ mice, the number of a-smooth muscle actin-positive
cells was reduced to 20%, and positive cells were scattered,
indicating a migration defect in the precursor fibroblasts (Figures
6C–6E). Other cell migration events at the wound site induced by
wounding include the recruitment of leukocytes to chemoattrac-
tants released by the wounded epithelium and degranulating
platelets. Compared to unwounded skin (Figure 6F), F4/80-
positive macrophages were recruited in similar numbers to the
wounds of both wild-type and Rhog/ mice (Figure 6G). The
difference between fibroblast and macrophage recruitment
suggests that RhoG is necessary for migration toward synde-
can-4 ligands, such as fibronectin, but not other chemoattrac-
tants. Thus, Rhog/ mice exhibited a delay in wound contrac-
tion that resembled the reported defect of Sdc4/ mice
(Echtermeyer et al., 2001) and was indicative of a migration
defect of dermal fibroblasts, but not immune cells.
Fibroblast migration along linear fibronectin fibers can be
modeled by tracking migration over a fibrillar cell-derived matrix,
which reflects the wound environment in vivo (Figure S4). To test
the contribution of RhoG to fibronectin-guided migration, RhoG-
deficient cells were generated by either RNAi-mediated reduc-
tion of RhoG in human fibroblasts or isolation of primary embry-
onic fibroblasts from the transgenicmice. In both cases, reduced
RhoG expression compromised the ability of fibroblasts to
proceed persistently over a fibrillar matrix but had no effect on(F) Time course of H/0-stimulated activation of RhoG by effector pull-down a
experiments.
(G–I) The effect of syndecan-4 engagement on unbinding energy (G), removal o
the plasma membrane (I), following reduction of RhoG expression by RNAi. Sc
20 measurements per condition, obtained on 3 separate occasions.
(J) Multimolecular complexes associated with active (12G10, white bar) or inactive
fibroblasts expressing GFP-RhoG; recruitment of GFP-RhoG and caveolin relati
reprobed for talin as a control for selective recruitment to active integrin.
(K) H/0-regulatedmultimolecular complexes associated with b1-integrin-GFPwer
represent at least 25 measurements per condition from at least 3 separate expe
Error bars represent standard error of themean; significancewas tested by ANOV
Figure S3 and Movie S2.
Developmspeed of migration (Figures 7A–7G and Movie S3). The persis-
tence defect resembled that of Sdc4/ MEFs (Figures 7H–7J),
which fail to detect and respond to fibronectin (Bass et al.,
2007). If the signal from syndecan-4 to RhoG to caveolin were
linear, as proposed, one would expect disruption of multiple
components to have no additional effect on persistence, once
the cascade is broken. Therefore, we combined knockdown of
caveolin and RhoG in wild-type or Sdc4/ MEFS, and found
that removal of multiple molecules had no greater effect than
removal of a single component (Figures 7K and 7L). Together,
these experiments identify the syndecan-4-RhoG-caveolin
pathway as a regulator of directional migration that enables
fibroblast immigration as part of a healing response.
Fibroblasts are not the only cell type to exhibit altered
syndecan-4 expression upon skin wounding. Keratinocytes
upregulate syndecan-4 expression around a wound (Gallo
et al., 1996) and, like fibroblasts, exhibit altered adhesion char-
acteristics when exposed to the H/0 fragment of fibronectin
(Wilke et al., 1993). We isolated primary keratinocytes and found
that RhoG/ keratinocytes exhibited reduced migration when
compared with wild-type or heterozygous equivalents in a
scratch wound assay (Figure 7M and Movie S4). Therefore,
when analyzing cell types that migrate during a wound response,
we find that migration of fibronectin-responsive cell types
depends on the RhoG signaling axis, whereas others, such as
macrophages, do not. When coupled with the fact that synde-
can-4 and RhoG knockouts are nonlethal, unlike integrin gene
deletions (Hynes, 2002), the role of syndecan-4 in controlling
fibronectin-dependent integrin redeployment during the healing
process makes syndecan-4 a logical therapeutic target for the
manipulation of integrin-dependent migration.
DISCUSSION
In this study, we have elucidated a signaling pathway that
controls the cell-surface delivery of a5b1-integrin during wound
healing. Intriguingly, this pathway is initiated by ligand binding
to a distinct adhesion receptor, syndecan-4, which therefore
identifies the latter as a primary sensor of the adhesive microen-
vironment. Our key findings are: (1) syndecan-4 engagement
reduces cell avidity for fibronectin, contrary to expectation; (2)
syndecan-4 regulates surface availability, rather than activity of
a5b1-integrin; (3) syndecan-4 triggers rapid endocytosis of pre-
formed integrin complexes, enriched in inactive integrin, through
a caveolin-dependent pathway; (4) activation of RhoG, down-
stream of PKCa, mediates the endocytic signal; and (5) Sdc4/,
Rhog/, and Cav1/ mice suffer similar wound closuressay, followed by quantitative western blotting. Gels represent six separate
f b1-integrin-GFP from the TIRF plane (H), and association of b1-integrin with
ale bars represent 5 mm. All atomic force measurements represent at least
(mAb13, black bar) b1-integrin or transferrin receptor (OKT9) were isolated from
ve to b1-integrin was determined by quantitative western blotting. Blots were
e isolated by GFP-Trap fromMEFs spread on 50K. Atomic forcemeasurements
riments. Gels represent five separate experiments.
A. Arrowheadsmark immunoglobulin bands. Ctrl, control; Tub, tubulin. See also
ental Cell 21, 681–693, October 18, 2011 ª2011 Elsevier Inc. 689
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Figure 6. RhoG Expression Is Required for Efficient Wound Closure
(A) Closure of 4 mm punch wounds in 7-week-old mice was compared
between Rhog/ mice (cross), wild-type (closed triangle), and heterozygous
(open square) littermates.
(B) Trichrome staining of skin sections to show comparable tissue morphology
but compromised wound contraction of Rhog/ mice; squares indicate the
regions analyzed for myofibroblast recruitment.
(C–G) Myofibroblast recruitment was measured by a-smooth muscle actin
staining (C), generation of intensity threshold masks (D), and automated
quantification of positive cells (per 0.23 mm2 image) (E) from wild-type and
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fibroblast migration episodes in vivo. Collectively, these findings
describe a model of integrin redeployment whereby exposure of
fibroblasts to fibronectin, upon wounding, results in fibroblast
migration to repair the defect.
Our observation of the reduction in cell avidity for fibronectin
was initially surprising because many studies have described
syndecan-4-dependent reinforcement of focal adhesions by
recruitment of cytoskeletal proteins such as vinculin (Bass
et al., 2007). However, enhanced integrin trafficking would
be consistent with syndecan-4-regulated activation of Rac1-
dependent membrane protrusion (Bass et al., 2007) and inhibi-
tion of RhoA-dependent contraction (Bass et al., 2008) at the
leading edge. Activation of RhoG and Rac1 and redeployment
of a5b1-integrin could be classed as early-phase migratory
events and define syndecan-4 as the initial sensor for fibronectin,
which initiates fibroblast migration into the wound bed. Because
cell migration requires cycles of membrane protrusion and
cytoskeletal contraction, the stabilization of integrin-containing
adhesions behind the leading edge, through the reactivation of
RhoA (Dovas et al., 2006), could be classed as late-phase events
and will play an equally important role in fibroblast migration.
If we are to understand fibronectin-dependent signaling fully,
further investigation will be required to resolve the interdepen-
dence of GTPase activation and receptor trafficking. The Rac1
regulation that we reported previously (Bass et al., 2007) does
not appear to be a direct consequence of a5b1-integrin traf-
ficking because H/0 stimulation of fibroblasts in suspension
causes integrin redistribution (Figure 5H), but not Rac1 regula-
tion (Bass et al., 2007). Localization of active Rac1 to the leading
edge is known to be integrin dependent (del Pozo et al., 2004)
and mediated by the sequestration of pY14-caveolin, whereas
GTP loading of Rac1 is syndecan-4 dependent (Bass et al.,
2007) and may even require clathrin-dependent endocytosis
of inactive Rac1 (Palamidessi et al., 2008). Conversely, Rac1
activation does not appear to be the driving force behind
integrin endocytosis because active Rac1 does not associate
with caveolar vesicles or drive endocytosis in the same way as
active RhoG (Prieto-Sa´nchez et al., 2006) and could not be de-
tected in our integrin immunoprecipitation experiments. Thus,
it appears that each of the protrusive signals is interconnected
but that none is exclusively dependent on another. The next
challenge will be the determination of how integrin organizes
the caveolin microdomains, necessary for localized Rac1
signaling, and whether syndecan-4 regulates the process.
It is interesting to speculate that the temporal coordination of
events may well depend on the proximity of the molecules
involved. The very short response time of cells touched onto
fibronectin is consistent with the endocytosis of a preformed
complex, and we have demonstrated biochemically the pres-
ence of RhoG and caveolin in a b1-integrin complex. Syndecan-4
is reported to colocalize with integrins in focal adhesions
(Woods et al., 2000), but the distribution of unengaged receptors
is not resolved. If we extrapolate the model of hair triggerRhog/ mice. Density of macrophages was compared between unwounded
(F) and wounded skin (G) of wild-type and Rhog/ mice.
Data represent 14 wounds per genotype. Error bars represent standard error
of the mean; significance was tested by ANOVA. Scale bars represent 100 mm.
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Figure 7. Migration of RhoG or Syndecan-4-Defient Fibroblasts over a Fibrillar Matrix
(A–L) Migration paths (A, E, and H), average speed (C, F, I, K, and L), and average persistence (= displacement/total distance moved) (D, G, and J–L) of
cells migrating over a cell-derived matrix. Gray boxes indicate the minimum possible persistence values when cells migrate randomly on homogeneous matrix.
Cells tracked were as follows: immortalized human fibroblasts transfected with control or RhoG-targeted siRNA (A–D), including analysis of expression of
RhoG by western blot (B); primary E13.5 MEFs from Rhog/ mice, wild-type, and heterozygous littermates (E–G); immortalized MEFs from wild-type and
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and syndecan-4 in microclusters with caveolin and RhoG. The
force required to break individual interactions between a5b1-in-
tegrin and fibronectin has been recorded as 39 ± 8 pN (Sun
et al., 2005). The force release events that we record during
cell detachment range from 37 to 175 pN (Figure 2A); these
data are consistent with the presence of microclusters contain-
ing one to five a5b1-integrins. The fact that the force distribution
does not change after H/0 stimulation suggests that the mecha-
nism of syndecan-4 action is not based upon increased clus-
tering of unengaged a5b1-integrin. The more rapid response to
H/0 than PKC-activator, PMA action, also relies on proximity of
syndecan-4 and a5b1-integrin, even before fibronectin binding.
We speculate that the complete a5b1-integrin-syndecan-4
cluster is internalized in response to syndecan-4 engagement,
and although a paucity of antibodies has prevented direct dem-
onstration of this point, vesicular colocalization of syndecan-2
with b1-integrin has been reported (Zimmermann et al.,
2005). The generation of improved reagents for detecting
syndecan-4, followed by high-resolution analyses of receptor
distribution, is a high priority.
The role of syndecan-4 as a sensor of tissue damage in vivo is
now apparent, and identification of molecules downstream of
syndecan-4 has allowed us to resolve the mechanism of fibro-
blast recruitment during tissue repair. Sdc4, RhoG, and Cav1
null mice each share a wound healing defect that can be attrib-
uted to a loss of persistent fibroblast migration (Figures 6 and
7; Echtermeyer et al., 2001; Grande-Garcı´a et al., 2007).
Although the fundamental roles of a5b1-integrin and Rac1 in
development render null mice embryonic lethal, there is a clear
role for these molecules in tissue repair. Expression of a5b1-in-
tegrin is induced upon wounding (Hynes, 2002), and mice with
a fibroblast-specific Rac1 deletion suffer healing delay, wound
contraction, and fibroblast migration defects that are com-
parable to those observed in the Sdc4/ mouse (Liu et al.,
2009). The possibility of syndecan-4 modulating the behavior
of integrin and Rac1, without the deleterious side effects associ-
ated with targeting the molecules directly, makes syndecan-4
an attractive target for wound treatment.
EXPERIMENTAL PROCEDURES
Sample Preparation
For all experiments cells were treated with 25 mg/ml cycloheximide for 2 hr
prior to detachment and throughout the experiment, to prevent synthesis of
fibronectin and other syndecan-4 ligands.
AFM
Force measurements were made using a CellHesion200 atomic force head
(JPK Instruments). Cells were mounted on 50K-coated tipless silicon SPM-
sensor cantilevers (NanoWorld), using Brightfield optics to ensure the capture
of individual cells. Captured cells were allowed to rest for 20 min before taking
measurements, and in each case the first measurement was discarded. Canti-
lever-mounted cells were contacted with FluoroDish coated with patches ofSdc4/ littermates and MEFs rescued by endogenous syndecan-4 expressio
caveolin- or RhoG-targeted siRNA. Data represent analysis of over 100 cells per
(M) Ten hour scratch assay of primary keratinocytes isolated from neonatal Rhog
Error bars represent standard error of the mean; significance was tested by
Arrowheads mark immunoglobulin bands. See also Figure S4 and Movies S3 an
692 Developmental Cell 21, 681–693, October 18, 2011 ª2011 Elsevfibronectin and 50K, at equivalent ligand density, with an applied force of 1
nN, a 5 s contact time, and 45 s intervals between measurements to allow
cell recovery. For stimulation experiments, baseline measurements of
unbinding from 50K and fibronectin were made before injecting the soluble
stimulant into the dish. Force curves were analyzed using JPK data analysis
software with baseline and tilt correction. For analysis of force release of indi-
vidual unbinding events, steps were fitted with a significance of p < 0.001.
TIRF Microscopy
Internalization of b1-integrin-GFP was recorded by TIRF at a 70 nm penetration
depth. Images were acquired for 5 min on 50K before addition of H/0 or H/0
complexed with heparin (10 mg/ml each) and image acquisition for a further
5 min. Movies were analyzed, using ImageJ, by outlining 20 focal adhesions
per cell and recording depreciation in intensity over 1 min segments, ensuring
that the analysis area remained centered over the adhesion for the duration of
analysis.
Membrane Fractionation
Cells spread on 50K-coated dishes and stimulated with 10 mg/ml H/0were har-
vested at 4C by scraping in PBS containing calcium and magnesium.
Membranes were fragmented by three 12 J pulses using a Vibra-Cell sonicator
(Sonics), before removing nuclear debris with a 10min, 10003 g centrifugation
step. Membranes were separated into plasma membrane pellet and vesicle/
soluble supernatant by 10 min centrifugation at 10,000 3 g.
GTPase Activity Assay
Active RhoG was affinity precipitated using GST-ELMO2 (amino acids 1–362).
Integrin Complexes
Activity-specific multimolecular integrin complexes were isolated on para-
magnetic beads, coated with 200 mg/ml antibody. Fibroblasts expressing
GFP-RhoG were incubated with beads for 20 min at room temperature and
complexes stabilized with DTBP membrane-permeable crosslinker, before
lysing cells by sonication. Matrix-dependent integrin complexes were isolated
by GFP-Trap capture of GFP-b1-integrin from MEFs spread on 50K-coated
dishes, stimulated with H/0, and crosslinked with DTBP.
Wound Healing
All experiments were carried out at the University of Bristol according to UK
HomeOffice regulations. Seven 7-week-oldmicewere anesthetized by isoflur-
ane inhalation. Four full-thickness excisional wounds were made on the
shaved back on either side of the dorsal midline with a 4 mm biopsy punch
(Kai Industries). Wound closure was recorded macroscopically by photo-
graphing the live mice daily until the wound had closed, and analyzing images
using ImageJ. Histological analysis was conducted 3 days postwounding.
Migration Analysis
Cell-derived matrices were generated as described previously (Bass et al.,
2007) by culturing confluent fibroblasts for 10 days before removing the fibro-
blasts by NH4OH lysis. For migration, cells were spread for 4 hr before imaging
every 10 min for 10 hr. The migration paths of all nondividing, nonclustered
cells were tracked, and persistence was determined by dividing linear
displacement of a cell by the total distance migrated.
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